NAVITOR PHARMACEUTICALS Trademark

Trademark Overview


On Monday, June 22, 2015, a trademark application was filed for NAVITOR PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the NAVITOR PHARMACEUTICALS trademark a serial number of 86670511. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 29, 2019. This trademark is owned by Navitor Pharmaceuticals, Inc.. The NAVITOR PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention, treatment and diagnosis of cancer, diabetes, and heart disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, and Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of immune disorders, namely, psoriasis, rheumatoid arthritis, lupus, Chron's disease, inflammatory bowel disease, and multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of metabolic, endocrine, cardiovascular, oncological, gastrointestinal, musculoskeletal, mitochondrial, autoimmune, and neurological related diseases and disorders; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of rare genetic diseases; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of...
navitor pharmaceuticals

General Information


Serial Number86670511
Word MarkNAVITOR PHARMACEUTICALS
Filing DateMonday, June 22, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 29, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2016

Trademark Statements


Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment and diagnosis of cancer, diabetes, and heart disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, and Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of immune disorders, namely, psoriasis, rheumatoid arthritis, lupus, Chron's disease, inflammatory bowel disease, and multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of metabolic, endocrine, cardiovascular, oncological, gastrointestinal, musculoskeletal, mitochondrial, autoimmune, and neurological related diseases and disorders; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of rare genetic diseases; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of Leigh's syndrome, Friedrich's ataxia, lymphangioleiomyomatosis (LAM) and tuberous sclerosis; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of obesity and obesity related diseases; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of age-related diseases; pharmaceutical preparations and substances for modulating the catabolic or anabolic response to nutrients; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of any disease related to muscle wasting diseases and conditions, including, cachexia, sarcopenia and muscle wasting due to prolonged immobilization; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting caloric intake and absorption; pharmaceuticals, therapeutics and nutraceuticals for use as active ingredients in foods, namely, dietary supplements; pharmaceuticals, therapeutics and nutraceuticals for use as food additives for medical purposes, namely, amino acids; dietetic substances for medical purposes, namely, dietetic foods such as dietary beverage supplements adapted for medical use; nutritional additives for medical purposes, namely, amino acids; pharmaceutical preparations and substances for the modulation of appetite, namely, appetite suppressants and satiety inducers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 27, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNavitor Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Party NameNavitor Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events


Event DateEvent Description
Monday, July 29, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 29, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2018EXTENSION 5 GRANTED
Tuesday, December 4, 2018EXTENSION 5 FILED
Tuesday, December 4, 2018TEAS EXTENSION RECEIVED
Friday, June 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 20, 2018EXTENSION 4 GRANTED
Wednesday, June 20, 2018EXTENSION 4 FILED
Wednesday, June 20, 2018TEAS EXTENSION RECEIVED
Wednesday, June 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 12, 2018EXTENSION 3 GRANTED
Thursday, December 28, 2017EXTENSION 3 FILED
Thursday, March 22, 2018PETITION GRANTED - EXTENSION REQUEST FILED
Thursday, March 22, 2018NOTICE OF REVIVAL - E-MAILED
Monday, March 19, 2018COMMUNICATION RECEIVED FROM PETITIONER
Monday, March 19, 2018TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Friday, March 16, 2018INCOMPLETE PETITION NOTICE MAILED
Thursday, March 8, 2018ASSIGNED TO PETITION STAFF
Wednesday, February 7, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 24, 2018NOTICE OF REVIVAL - E-MAILED
Tuesday, January 23, 2018EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, January 23, 2018TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 23, 2017EXTENSION 2 GRANTED
Friday, June 23, 2017EXTENSION 2 FILED
Friday, June 23, 2017TEAS EXTENSION RECEIVED
Tuesday, December 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 9, 2016EXTENSION 1 GRANTED
Friday, December 9, 2016EXTENSION 1 FILED
Friday, December 9, 2016TEAS EXTENSION RECEIVED
Tuesday, June 28, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 25, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 5, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 5, 2015NON-FINAL ACTION E-MAILED
Monday, October 5, 2015NON-FINAL ACTION WRITTEN
Monday, September 28, 2015ASSIGNED TO EXAMINER
Monday, August 24, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 24, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 27, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 25, 2015NEW APPLICATION ENTERED IN TRAM